Page last updated: 2024-09-03

imatinib mesylate and Pain, Chronic

imatinib mesylate has been researched along with Pain, Chronic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barker, K; Diaz, M; Gutstein, HB; Mo, B; Shi, S; Wang, Y	1

Other Studies

1 other study(ies) available for imatinib mesylate and Pain, Chronic

Article	Year
Blockade of PDGFR-β activation eliminates morphine analgesic tolerance. Nature medicine, 2012, Feb-19, Volume: 18, Issue:3 Topics: Animals; Benzamides; Chronic Pain; Dose-Response Relationship, Drug; Drug Combinations; Drug Tolerance; Fentanyl; Glioma; Imatinib Mesylate; Morphine; Phosphorylation; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Rats; Receptor, Platelet-Derived Growth Factor beta; Receptors, Opioid, mu; Transcriptional Activation	2012

Article

Year

Blockade of PDGFR-β activation eliminates morphine analgesic tolerance.

Nature medicine, 2012, Feb-19, Volume: 18, Issue:3

Topics: Animals; Benzamides; Chronic Pain; Dose-Response Relationship, Drug; Drug Combinations; Drug Tolerance; Fentanyl; Glioma; Imatinib Mesylate; Morphine; Phosphorylation; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Rats; Receptor, Platelet-Derived Growth Factor beta; Receptors, Opioid, mu; Transcriptional Activation

2012